Literature DB >> 26651155

Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion.

Radek Kucera1, Zdenka Ulcova-Gallova2,3, Ondrej Topolcan1.   

Abstract

Anti-Müllerian hormone (AMH) is an important factor associated with female fertility and the ovarian reserve. There are several past studies available concerning the influence of hormonal contraception (HC) on serum AMH levels. Recent studies have reported that AMH levels in women using HC can be about 30% lower compared to those not using HC. However, earlier studies showed no reduction in AMH levels in HC users. We decided to evaluate the effects of long-term HC use (mean duration of HC use: 11.4 years) on AMH levels in women. To exclude potential shorter and reversible decreasing effects of HC on fertility function, we decided to include women in the study who had stopped using HC 1 year before the AMH sample collection. We examined 105 women who used HC and 44 women who had never used HC. The median concentration of AMH in the group of long-term users of HC was 2.89 and 3.37 ng/ml in the group of women who had never used HC. We found no statistically significant difference (p = 0.3261). In conclusion, we observed no negative impact of HC on the AMH serum levels. AMH can be used as an ovarian reserve marker for these women.

Entities:  

Keywords:  Anti-Müllerian hormone; hormonal contraception; ovarian reserve; serum sample

Mesh:

Substances:

Year:  2015        PMID: 26651155     DOI: 10.3109/09513590.2015.1121981

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis.

Authors:  Wei-Wei Yin; Chang-Chang Huang; Yi-Ru Chen; Dan-Qing Yu; Min Jin; Chun Feng
Journal:  BMC Endocr Disord       Date:  2022-06-14       Impact factor: 3.263

2.  Association of oral contraceptives and tubal ligation with antimüllerian hormone.

Authors:  Christine R Langton; Brian W Whitcomb; Alexandra C Purdue-Smithe; Lynnette L Sievert; Susan E Hankinson; JoAnn E Manson; Bernard A Rosner; Elizabeth R Bertone-Johnson
Journal:  Menopause       Date:  2021-12-06       Impact factor: 2.953

3.  Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels.

Authors:  Lia A Bernardi; Marissa Steinberg Weiss; Anne Waldo; Quaker Harmon; Mercedes R Carnethon; Donna D Baird; Lauren A Wise; Erica E Marsh
Journal:  Fertil Steril       Date:  2021-03-19       Impact factor: 7.490

4.  Marked reduction in fertility among African women with urogenital infections: A prospective cohort study.

Authors:  K Perslev; O A Msemo; D T R Minja; S L Møller; T G Theander; J P A Lusingu; I C Bygbjerg; B B Nielsen; C Schmiegelow
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

5.  Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.

Authors:  Monika Sarkar; Jennifer L Dodge; Ruth M Greenblatt; Mark H Kuniholm; Jack DeHovitz; Michael Plankey; Andrea Kovacs; Audrey L French; Eric C Seaberg; Igho Ofotokun; Margaret Fischl; Edgar Overton; Erin Kelly; Peter Bacchetti; Marion G Peters
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.